Abstract:Snakebite in the Middle East and North Africa (MENA) is a public health problem whose magnitude is not fully known. Several antivenoms are available in these regions, but these formulations are designed for restricted geographical settings. Many countries do not have local production of antivenoms and must access products whose clinical performance has not been demonstrated. We hypothesize that it is possible to unify the treatment for viperid snakebites of MENA in a single antivenom formulation. Hereby we describe the design, development and preclinical evaluation of an antivenom of broad geographical coverage for this region (MENAVip-ICP). We produced this antivenom from the plasma of horses immunized with eight medically important venoms of viperid snake species from MENA. For this, we used a strategy based on two stages: first, immunization of horses with North African (NA) venoms, followed by a second immunization stage, on the same horses, with MENA venoms. We purified antivenoms from both stages: the Anti-NA and the final product Anti-MENA (MENAVip-ICP). Anti-NA was considered as intermediate formulation and was purified with the intention to study the progression of the immunoglobulin immune response of the horses. Antivenoms from both stages neutralized lethal, hemorrhagic, and procoagulant activities of homologous venoms. Compared to Anti-NA, MENAVip-ICP improved the neutralization profile of intravenous lethality and in vitro procoagulant activities of venoms. A notable finding was the difference in the neutralization of lethality when MENAVip-ICP was assessed intraperitoneally versus intravenously in the murine model. Intraperitoneally, MENAVip-ICP appears more effective in neutralizing the lethality of all venoms. Furthermore, MENAVip-ICP neutralized the lethal activity of venoms of species from other regions of MENA, Central/East Asia, and Sub-Saharan Africa that were not included in the immunization protocol. Our results showed that MENAVip-ICP neutralizes the main toxic activities induced by viperid MENA venoms at the preclinical level. Consequently, it is a promising product that could be clinically assessed for the treatment of snakebite envenomings in this region.

Induction of a latent herpes simplex virus from a rat tumour initiated by herpes simplex virus-transformed cells.

Development of a Biosensor to Detect Venom of Malayan Krait (Bungarus candidus)

Detection of Western Diamondback Rattlesnake (C. atrox) venom using Glycopolymer Functionalised Gold Nanoparticles

Computer assisted transcutaneous oxygen monitoring.

The complete amino-acid sequence of histone H2B(2) from sperm of the sea urchin Parechinus angulosus.

Smoking cessation services in U.S. methadone maintenance facilities.

Mycotoxin Detection through Colorimetric Immunoprobing with Gold Nanoparticle Antibody Conjugates

Development and Validation of a Ligand-Binding Assay for Quantification of the F(ab')2 Antivenom of Daboia Russelii Siamensis in Human Serum and Its Application to a Phase I Clinical Study

Supplementation of polyclonal antibodies, developed against epitope-string toxin-specific peptide immunogens, to commercial polyvalent antivenom, shows improved neutralization of Indian Big Four and Naja kaouthia snake venoms

Plug and play virus-like particles for the generation of anti-toxin antibodies

An amplified voltammetric immunosensor for detection of porcine serum albumin using a self-standing nanohybrid composed of multi-walled carbon nanotubes, polyelectrolytes, and gold nanoparticles

Single Chain Fragment Variable Recombinant Antibody Functionalized Gold Nanoparticles For A Highly Sensitive Colorimetric Immunoassay

Mass spectrometric analysis to unravel the venom proteome composition of Indian snakes: opening new avenues in clinical research

Development and characterization of nanobody against envenomation by Naja naja oxiana

Harnessing the Cross-Neutralisation Potential of Existing Antivenoms for Mitigating the Outcomes of Snakebite in Sub-Saharan Africa

Relation of immune semaphorin/plexin signaling to carcinogenesis

A comparison of two different analytical workflows to determine the venom proteome composition of Naja kaouthia from North-East India and immunological profiling of venom against commercial antivenoms

Post-traumatic osteolysis of the distal clavicle

Design, development and preclinical assessment of MENAVip-ICP, a new snake antivenom with potential coverage of species in the Middle East and North Africa regions

Detection and neutralization of cobra venom using rabbit antiserum in experimental envenomated mice

A Strategy for Efficient Preparation of Genus-Specific Diagnostic Antibodies for Snakebites